Results 71 to 80 of about 12,482 (250)

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

Clinical &Experimental Allergy, EarlyView.
Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić, Marta Paolucci, Alessandro Streuli, David A. Melillo, Tianchi Jiang, Raffaela Campana, Claudia C. V. Lang, Thomas M. Kündig, Christian Steuer, Klaus Eyer, Pål Johansen   +10 more
wiley   +1 more source

Estudo comparativo entre duas técnicas de irrigação nasal no tratamento de pacientes com rinite alérgica. [PDF]

, 2006
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Duarte, Juliana Antoniolli
core  

Allergic Rhinitis

South African Family Practice, 2005
Instead of considering allergic rhinitis as a disease of acute symptoms, it needs to be understood as a chronic inflammatory disease that involves a level of persistent inflammation even in the absence of symptoms.
Sommers DeK
doaj   +1 more source

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, EarlyView.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. [PDF]

, 2015
BACKGROUND: Associations of larger families with lower prevalences of hay fever, eczema and objective markers of allergic sensitization have been found fairly consistently in affluent countries, but little is known about these relationships in less ...
Strachan, DP, Foliaki S, Mallol, J, Odhiambo, J, Strachan DP, Aït-Khaled N, Pearce, N, Foliaki, S, Mallol J, Williams HC, Williams, HC, Pearce N, Odhiambo J, ISAAC Phase Three Study Group, Aït-Khaled, N   +14 more
core   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

Clinical &Experimental Allergy, EarlyView.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng, Prawira Oka, Ngiap Chuan Tan   +2 more
wiley   +1 more source

A Survey on Seasonal Symptoms in Subjects with and Without Allergic Rhinitis Diagnosis

In Switzerland, only scarce data are available on the prevalence and treatment of allergic rhinitis. Although the presence of AR symptoms in temporal relation to the respective aeroallergen is indicative, still a substantial number of affected ...
Victor Colin, Elisabeth Schuller, Annika Stern, Yannick D. Muller, Mathilde Foglierini, Arthur Helbling, Kaspar Strub   +6 more
core   +1 more source

Mechanisms and Comparative Treatments of Allergic Rhinitis including Phototherapy

Allergies
The treatment of allergic conditions presents a challenge for both seasonal allergic rhinitis and perennial rhinitis sufferers. The increasing prevalence of both of these types of allergic responses requires the use of a range of treatments which can ...
Roy Kennedy
doaj   +1 more source

Intranasal ciclesonide for allergic rhinitis

, 2008
Ben Williams, William B Smith, Frank E KetteDepartment of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South AustraliaAbstract: Ciclesonide is a novel corticosteroid which is optimized for topical use.
Ben Williams, Frank E Kette, William B Smith   +2 more
core  

A Randomized Placebo-Controlled Trial of Intradermal Grass Pollen Immunotherapy for Seasonal Allergic Rhinitis

, 2016
Rationale: We previously reported that repeated intradermal injection of grass pollen (nanograms of allergen) almost completely suppresses allergen-induced cutaneous late phase responses (JACI 2012 130(4):918-24). Similar suppression of late responses is
Shamji, Mohamed H., Ying, S, Durham, Stephen R, Peacock, Janet, Till, Stephen, Lam, Emily, Kelly, Joanna, Cousins, David, Guerra, Andrea, Shamji, Mohamed H, Ying, S., Tsioulos, Kostas, Haye, Evie, Slovick, Anna D, Durham, Stephen R., Till, Stephen; id_orcid, Douiri, Abdel; id_orcid, Muir, Rachel, Slovick, Anna D., Douiri, Abdel   +19 more
core   +1 more source